Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the genotypic and phenotypic spectrum of TCF7L2-related neurodevelopmental disorder (TRND).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

A Health Navigator intervention to identify and respond to the health-related social needs of an Australian population living with cancer: a mixed-methods feasibility study.

BMC health services research·2026
Same author

UPF3A and UPF3B Shape the Transcriptome Cooperatively Yet Oppose Cell Function.

Journal of molecular biology·2026
Same author

A Health Navigator intervention to address the health-related social needs of caregivers of hospitalised children in an Australian inpatient setting: a mixed-methods feasibility study.

BMC health services research·2026
Same author

Novel <i>PCDH12</i> pathogenic missense variants cause neurodevelopmental disorders with ocular malformation.

medRxiv : the preprint server for health sciences·2026
Same author

Testing the performance of polygenic scores for multiple traits to explain cerebral palsy in two independent cohorts.

EBioMedicine·2026

Related Experiment Video

Updated: May 12, 2026

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

Polyalanine tract disorders and neurocognitive phenotypes.

Cheryl Shoubridge1, Jozef Gecz

  • 1Department of Genetics and Molecular Pathology, SA Pathology at the Women's and Children's Hospital, North Adelaide, South Australia, Australia. cheryl.shoubridge@adelaide.edu.au

Advances in Experimental Medicine and Biology
|April 6, 2013
PubMed
Summary

Polyalanine tract expansions cause inherited diseases, often affecting transcription factors and leading to neurodevelopmental disorders. Understanding these polyalanine expansion mechanisms is crucial for developing future treatments.

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

Related Experiment Videos

Last Updated: May 12, 2026

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

Area of Science:

  • Genetics
  • Molecular Biology
  • Human Disease Pathogenesis

Background:

  • Polyalanine tract expansions are implicated in at least nine inherited human diseases.
  • Eight of these diseases result from expansions in transcription factors, causing congenital disorders with neurocognitive phenotypes.
  • Disease severity correlates with the length of the expanded polyalanine tract.

Purpose of the Study:

  • To review the current understanding of polyalanine tract expansions in inherited diseases.
  • To highlight the need for further research into the pathogenic mechanisms of these expansions.
  • To underscore the importance of mechanistic insights for developing therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research on polyalanine tract expansions.
  • Analysis of genetic and functional studies related to disease-causing mutations.
  • Discussion of the relationship between polyalanine tract length and disease phenotype.

Main Results:

  • Significant progress has been made in understanding the origin and functional impact of expanded polyalanine tracts.
  • The precise pathogenic mechanisms underlying expanded polyalanine tract diseases remain largely unclear.
  • The length of polyalanine expansions is a key determinant of disease severity.

Conclusions:

  • Expanded polyalanine tracts represent a significant cause of inherited human diseases, particularly those affecting transcription factors.
  • Despite advances, a deeper understanding of the molecular pathogenesis is essential.
  • Elucidating these mechanisms is a prerequisite for designing effective treatments for polyalanine expansion disorders.